Delix Therapeutics Announces 2 Partners in Neuroscience Drug Discovery Effort

The neuroscience discovery company alter the molecular chemistry of existing psychedelic drugs to maintain their psychoplastogenic properties but remove their hallucinogenic effects.

Read More


Comments

Leave a Reply

Your email address will not be published. Required fields are marked *